United States· US:68475-003_76819c30-2ece-43cf-a329-6bc3720ac870
RIBAVIRIN
A medicinal product containing ribavirin, registered in United States by Navinta LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- RIBAVIRIN
- Manufacturer
- Navinta LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- August 9, 2026
Packs & prices · 2
- ndc1168475003044 VIAL in 1 CARTON (68475-003-04) / 1 POWDER, FOR SOLUTION in 1 VIAL
- ndc1168475-003-04
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ribavirin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaVIRAZOLEBAUSCH HEALTH, CANADA INC.
- BelgiumCopegus 200 mgRoche
- FinlandCopegusRoche Oy
- United KingdomCopegus 200mg tabletsRoche Products Ltd
- SpainREBETOL 200 MG CAPSULAS DURASMerck Sharp & Dohme B.V.
- FranceREBETOL 40 mg/ml, solution buvableMERCK SHARP & DOHME (PAYS-BAS)
- NetherlandsRibavirine ratiopharm 200 mg, filmomhulde tablettenratiopharm GmbH
- NorwayRibavirin aurobindoAurobindo
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Cyprus · Ribavirin Aurobindo
- Germany · Ribavirin Ratiopharm
- Spain · Ribavirina Normon
- France · Ribavirine Pharmadev, Ribavirine Skyepharma
- United Kingdom (Northern Ireland) · Ribavirin Milpharm
- Italy · Ribavirina Aurobindo
- Netherlands · Ribavirine Ratiopharm
- Portugal · Ribavirina Aurobindo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c944a6ec-af4e-48fc-bade-37c7b5f8e6c5 GET /v1/drugs/c944a6ec-af4e-48fc-bade-37c7b5f8e6c5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "RESPIRATORY (INHALATION)",
"source": "ndc",
"strength": "6",
"substance": "RIBAVIRIN",
"productndc": "68475-003",
"dosage_form": "POWDER, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "g/1",
"application_number": "ANDA207366",
"marketing_category": "ANDA"
}See everything about ribavirin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.